ARTICLE

FREQUENCY IMPACT AND RISK FACTORS OF FATIGUE IN PATIENTS WITH MULTIPLE SCLEROSIS

  1. HOME
  2. ARTICLE

07 Pages : 53-63

http://dx.doi.org/10.31703/giidr.2024(IX-III).07      10.31703/giidr.2024(IX-III).07      Published : Sep 2024

Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis

Abstract

    Fatigue is one of the most common and debilitating symptoms affecting 75–90% of individuals with multiple sclerosis (MS), significantly impacting their quality of life. This study aimed to assess the prevalence, effects, and risk factors of fatigue among MS patients in Quetta, Pakistan. A cross-sectional descriptive design involved 34 participants aged 20–50 years from Bolan Medical Complex Hospital and nearby facilities. The Fatigue Severity Scale(FSS) was used to evaluate the impact of fatigue on functionality and well-being. Findings revealed that 11 patients experienced severe fatigue due to lack of exercise, and 8 linked it to depression. MRI showed lesions in 4 out of 5 patients with severe fatigue. Additionally, 71% reported worsening of other symptoms due to fatigue. The study highlights fatigue in MS as a complex issue requiring integrated management strategies and contributes to addressing gaps in literature to improve healthcare policies and patient quality of life.

    Frequency, Impact, Risk Factors of Multiple Sclerosis in Patients, Pakistan

    (1) Mahmood Khan
    Postgraduate Resident, Department of Neurology, Bolan Medical Complex and Hospital (BMCH), Quetta, Baluchistan, Pakistan.
    (2) Muhammad Abbas Khan
    Medical Officer, Department of Neurology, Pakistan Emirates Military Hospital(PEMH), Rawalpindi, Punjab, Pakistan.
    (3) Gohar Shah
    MPhil Scholar, Department of Biochemistry, University, of Balochistan (UOB), Quetta, Balochistan, Pakistan.
    (4) Sana Ullah
    PhD Scholar, Department of Zoology, University, of Balochistan (UOB), Quetta, Balochistan, Pakistan.
    (5) Muhammad Nawaz
    PhD Scholar, Department of Zoology, University, of Balochistan (UOB), Quetta, Balochistan, Pakistan.
Fulltext PDF

References

  • Yewande, T., & Olawunmi, A. (2023). Exploring the impact of cultural beliefs an

  • Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S.

  • Cordone, S., Alfonsi, V., & De Gennaro, L. (2023). The Role of Sleep in Multiple Sclerosis. .

  • Newton, G., Griffith, A., & Soundy, A. (2016). The experience of fatigue in neurological patients with Multiple Sclerosis: a thematic synthesis. Physiotherapy, 107, 306–316.

  • Hosseini, Z., Homayuni, A., & Etemadifar, M. (2022). Barriers to quality of life in patients with multiple sclerosis: a qualitative study. BMC Neurology, 22(1).

  • Macaron, G., Larochelle, C., Arbour, N., Galmard, M., Girard, J. M., Prat, A., & Duquette, P. (2023). Impact of aging on treatment considerations for multiple sclerosis patients. Frontiers in Neurology, 14.

  • Eizaguirre, M. B., Ciufia, N., Roman, M. S., Canyazo, C. M., Alonso, R., Silva, B., Pita, C., Garcea, O., & Vanotti, S. (2020). Perceived fatigue in multiple sclerosis: The importance of highlighting its impact on quality of life, social network, and cognitio

  • Yi, X., Zhang, Y., Du, Q., Kang, J., Song, S., Li, T., & Jiang, Y. (2024). Global prevalence of fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. Frontiers in Neurology, 15.

  • Ismail, I. I., & Saqr, M. (2022). A quantitative synthesis of eight decades of global multiple sclerosis research using bibliometrics. Frontiers in Neurology, 13.

  • AlSaeed, S., Aljouee, T., Alkhawajah, N. M., Alarieh, R., AlGarni, H., Aljarallah, S., Ayyash, M., & Abu-Shaheen, A. (2022). Fatigue, depression, and anxiety among ambulating multiple sclerosis patients. Frontiers in Immunology, 13.

  • Zeine, R. R., & Teasdale, B. W. (Eds.). (2023). Medical cannabis and the effects of cannabinoids on fighting cancer, multiple sclerosis, epilepsy, Parkinson's, and other neurodegenerative diseases. IGI Global.

  • Razazian, N., Kazeminia, M., Moayedi, H., Daneshkhah, A., Shohaimi, S., Mohammadi, M., Jalali, R., & Salari, N. (2020). The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC

  • Marchesi, O., Vizzino, C., Filippi, M., & Rocca, M. A. (2022). Current perspectives on the diagnosis and management of fatigue in multiple sclerosis. Expert Review of Neurotherapeutics, 22(8), 681–693.

  • Ayache, S. S., Serratrice, N., Lahoud, G. N. A., & Chalah, M. A. (2022). Fatigue in Multiple Sclerosis: A Review of the Exploratory and Therapeutic Potential of Non-Invasive Brain Stimulation. Frontiers in Neurology, 13.

  • Gianni, E. (2023). A treatment of precision electroceuticals: Fatigue relief in multiple sclerosis with personalized home-neuromodulation.

  • Ayache, S. S., & Chalah, M. A. (2017). Fatigue in multiple sclerosis – Insights into evaluation and management. Neurophysiologie Clinique, 47(2), 139–171.

  • Sellitto, G., Morelli, A., Bassano, S., Conte, A., Baione, V., Galeoto, G., & Berardi, A. (2021). Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research<

  • Herring, T. E., Alschuler, K. N., Knowles, L. M., Phillips, K. M., Morean, W. M., Turner, A. P., & Ehde, D. M. (2021). Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis. Multiple Sclerosis and Related Disord

  • Rooney, S., Wood, L., Moffat, F., & Paul, L. (2019). Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 28, 276–282. <

Cite this article

APA

    APA : Khan, M., Khan, M. A., & Shah, G. (2024). Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis. Global Immunological & Infectious Diseases Review, IX(III), 53-63. https://doi.org/10.31703/giidr.2024(IX-III).07

CHICAGO

    CHICAGO : Khan, Mahmood, Muhammad Abbas Khan, and Gohar Shah. 2024. "Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis." Global Immunological & Infectious Diseases Review, IX (III): 53-63 doi: 10.31703/giidr.2024(IX-III).07

HARVARD

    HARVARD : KHAN, M., KHAN, M. A. & SHAH, G. 2024. Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis. Global Immunological & Infectious Diseases Review, IX, 53-63.

MHRA

    MHRA : Khan, Mahmood, Muhammad Abbas Khan, and Gohar Shah. 2024. "Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis." Global Immunological & Infectious Diseases Review, IX: 53-63

MLA

    MLA : Khan, Mahmood, Muhammad Abbas Khan, and Gohar Shah. "Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis." Global Immunological & Infectious Diseases Review, IX.III (2024): 53-63 Print.

OXFORD

    OXFORD : Khan, Mahmood, Khan, Muhammad Abbas, and Shah, Gohar (2024), "Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis", Global Immunological & Infectious Diseases Review, IX (III), 53-63

TURABIAN

    TURABIAN : Khan, Mahmood, Muhammad Abbas Khan, and Gohar Shah. "Frequency, Impact, and Risk Factors of Fatigue in Patients with Multiple Sclerosis." Global Immunological & Infectious Diseases Review IX, no. III (2024): 53-63. https://doi.org/10.31703/giidr.2024(IX-III).07